ERGO (Entia Biosciences) Scaled Net Operating Assets: -2.72 (As of Dec. 2016)


What is Entia Biosciences Scaled Net Operating Assets?

Entia Biosciences ERGO Scaled Net Operating Assets is -2.72 as of Dec. 2016.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Entia Biosciences's operating assets for the quarter that ended in Dec. 2016 was $0.36 Mil. Entia Biosciences's operating liabilities for the quarter that ended in Dec. 2016 was $1.36 Mil. Entia Biosciences's Total Assets for the quarter that ended in Sep. 2016 was $0.37 Mil. Therefore, Entia Biosciences's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2016 was -2.72.

Entia Biosciences Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Entia Biosciences's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entia Biosciences Scaled Net Operating Assets Chart

Entia Biosciences Annual Data
Trend Jul07 Jul08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.51 -1.22 0.35 -0.62 -2.22

Entia Biosciences Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 -1.48 -2.26 -2.73 -2.72

ERGO vs OBMP, NSPX, ATRX: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Entia Biosciences's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entia Biosciences Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entia Biosciences's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Entia Biosciences's Scaled Net Operating Assets falls into.


Entia Biosciences Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Entia Biosciences's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2016 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2016 )
=(Operating Assets (A: Dec. 2016 )-Operating Liabilities (A: Dec. 2016 ))/Total Assets (A: Dec. 2015 )
=(0.363-1.36)/0.449
=-2.22

where

Operating Assets(A: Dec. 2016 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.439 - 0.076
=0.363

Operating Liabilities(A: Dec. 2016 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.406 - 0.3 - 0.746
=1.36

Entia Biosciences's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2016 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2016 )
=(Operating Assets (Q: Dec. 2016 )-Operating Liabilities (Q: Dec. 2016 ))/Total Assets (Q: Sep. 2016 )
=(0.363-1.36)/0.366
=-2.72

where

Operating Assets(Q: Dec. 2016 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0.439 - 0.076
=0.363

Operating Liabilities(Q: Dec. 2016 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=2.406 - 0.3 - 0.746
=1.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of -2.72 mean?
Entia Biosciences (ERGO) has a Scaled Net Operating Assets of -2.72 as of Dec. 2016. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Entia Biosciences and its competitors.
Is Entia Biosciences' Scaled Net Operating Assets too high?
Entia Biosciences' current Scaled Net Operating Assets is -2.72.
How does Entia Biosciences' Scaled Net Operating Assets compare to OBMP and NSPX?
Entia Biosciences' Scaled Net Operating Assets of -2.72 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Entia Biosciences and its competitors. Entia Biosciences's current Scaled Net Operating Assets is -2.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entia Biosciences stock overvalued right now?
Entia Biosciences (ERGO) has a current Scaled Net Operating Assets of -2.72. The current Scaled Net Operating Assets is -2.72. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Entia Biosciences (ERGO), the current Scaled Net Operating Assets is -2.72 as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entia Biosciences Business Description

Address 13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.